Once GDPR has come into effect at the end of May and the dust has cleared, what is next for life science manufacturers? Most organizations have a plan that they are executing. They have assessed the risks, taken advice and put in place procedures that address at least some of the changes. However there is likely to be ongoing adjustments required for some time after the effective date as everyone gets experience with how things will work in practice. There is no definitive understanding on how the new rules will be policed and enforced in practice by regulators. Incorporating these measures into the business and being prepared for the unknown will remain heavily with legal, compliance and information security and technology teams.
CBI/UBM’s GDPR Forum for Life Sciences is a one-day summit dedicated to providing legal, compliance and IS/IT executive teams with best practices based on real-world examples, insights from data protection thought-leaders and opportunities for benchmarking across the industry.
KEY EXPLORATIONS AND SPECIAL FEATURES:
- Examine the role and responsibilities of data processors and controllers under GDPR in terms of data breaches and resulting liabilities
- Strengthen data protection impact assessments for enhanced risk planning
- Evaluate how the “right to erasure” impacts records already disclosed in EFPIA transparency reports
- Benchmark with data privacy team leaders to see how they are becoming GDPR-compliant while also anticipating the needs of the organisation
TRACE Members are entitled to an exclusive discount for this event. For more information, write to email@example.com.